Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors

伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性

基本信息

  • 批准号:
    10543076
  • 负责人:
  • 金额:
    $ 58.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-12-21 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Typhoid fever is one of the most successful and devastating infectious diseases in human history and remains a serious real-world problem that kills 0.2 million and sickens 21 million people every year. The etiological agent of typhoid fever is the gram-negative bacterium Salmonella enterica serovar Typhi (S. Typhi), which is adapted solely to humans. S. Typhi’s persistent-carriage infection state, exemplified by “Typhoid Mary,” is critical for person-to-person transmission and the continued maintenance of the bacterium within humans. If we are to effectively contain and eradicate typhoid fever, we need to implement strategies inhibiting S. Typhi’s transition to the persistent infection state. First, however, we must understand how S. Typhi facilitates transition from acute to a persistent/carriage infection state. In a humanized mouse model that serves as a S. Typhi’s persistent infection model, typhoid toxin, a distinct A2B5 toxin or exotoxin produced by intracellular S. Typhi, has been identified as a critical bacterial determinant facilitating the transition of S. Typhi infection to the persistent-carriage infection state. In this R01, we propose a series of experiments to better understand the typhoid toxin-mediated host cell interactive mechanism promoting S. Typhi’s persistent infection. The proposed research may provide critical information for the development of efficacious intervention strategies to better control S. Typhi’s transmission and outbreaks.
项目总结/摘要 伤寒是人类历史上最成功和最具破坏性的传染病之一, 这是一个严重的现实世界问题,每年造成20万人死亡,2100万人患病。病原 伤寒的病原体是革兰氏阴性细菌伤寒沙门氏菌(S.伤寒),这是适应 只对人类开放S.伤寒的持续携带感染状态,例如“伤寒玛丽”, 人与人之间的传播和细菌在人体内的持续维持。如果我们要 有效控制和消灭伤寒,我们需要实施抑制S.伤寒转变 持续感染状态首先,我们必须了解S。伤寒易从急性 持续/携带感染状态。在作为S.伤寒持续性 感染模型、伤寒毒素、由细胞内S.伤寒,已经 被鉴定为促进S.伤寒感染对持续带菌 感染状态。在这个R 01中,我们提出了一系列的实验,以更好地了解伤寒毒素介导的 宿主细胞相互作用机制促进S.伤寒持续感染。这项研究可能提供 为制定有效的干预策略以更好地控制S.伤寒 传播和爆发。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Direct IgG epitope mapping on bacterial AB toxins by cryo-EM.
  • DOI:
    10.1016/j.xpro.2021.100852
  • 发表时间:
    2021-12-17
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nguyen T;Song J
  • 通讯作者:
    Song J
Complete Genome Sequence of Salmonella enterica Serovar Typhi Strain ISP2825.
Neutralization of Typhoid Toxin by Alpaca-Derived, Single-Domain Antibodies Targeting the PltB and CdtB Subunits.
  • DOI:
    10.1128/iai.00515-21
  • 发表时间:
    2022-02-17
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Dulal HP;Vance DJ;Neupane DP;Chen X;Tremblay JM;Shoemaker CB;Mantis NJ;Song J
  • 通讯作者:
    Song J
Enteric Fever Diagnosis: Current Challenges and Future Directions.
  • DOI:
    10.3390/pathogens10040410
  • 发表时间:
    2021-04-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Neupane DP;Dulal HP;Song J
  • 通讯作者:
    Song J
Delivery, structure, and function of bacterial genotoxins.
  • DOI:
    10.1080/21505594.2022.2097417
  • 发表时间:
    2022-12
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeongmin Song其他文献

Jeongmin Song的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeongmin Song', 18)}}的其他基金

Cracking Salmonella Typhis Secret Code: Understanding Pathogenic Mechanisms of Salmonella Typhi Toxin
破解伤寒沙门菌密码:了解伤寒沙门菌毒素的致病机制
  • 批准号:
    10164712
  • 财政年份:
    2018
  • 资助金额:
    $ 58.14万
  • 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
  • 批准号:
    10425840
  • 财政年份:
    2018
  • 资助金额:
    $ 58.14万
  • 项目类别:
Cracking Salmonella Typhis Secret Code: Understanding Pathogenic Mechanisms of Salmonella Typhi Toxin
破解伤寒沙门菌密码:了解伤寒沙门菌毒素的致病机制
  • 批准号:
    10404508
  • 财政年份:
    2018
  • 资助金额:
    $ 58.14万
  • 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
  • 批准号:
    9762253
  • 财政年份:
    2018
  • 资助金额:
    $ 58.14万
  • 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
  • 批准号:
    10308674
  • 财政年份:
    2018
  • 资助金额:
    $ 58.14万
  • 项目类别:
Typhoid Vaccines Targeting Both Salmonella Typhi and Its Secreted Virulence Factor
针对伤寒沙门氏菌及其分泌的毒力因子的伤寒疫苗
  • 批准号:
    10403451
  • 财政年份:
    2018
  • 资助金额:
    $ 58.14万
  • 项目类别:
Typhoid Vaccines Targeting Both Salmonella Typhi and Its Secreted Virulence Factor
针对伤寒沙门氏菌及其分泌的毒力因子的伤寒疫苗
  • 批准号:
    10160775
  • 财政年份:
    2018
  • 资助金额:
    $ 58.14万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 58.14万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了